×
Argentum Logo_RGB2

What’s New?

  • CDC Publishes Updated Guidance for Fully Vaccinated Residents, Workers in Assisted Living
    Yesterday, the CDC published updated guidance calling for prioritization of visitation, dining, and a re-opening of group activities in assisted living communities. This guidance, which also includes recommendations for discontinuation of routine testing for asymptomatic staff, follows a series of discussions where Argentum advocated for such guidance specifically for the… Read more »
  • Expiration Date Extended on BinaxNOW Tests
    Users of the BinaxNOW™ COVID-19 Ag Card are urged to check the lot numbers and expiration dates of their tests. Abbott has informed users that further testing has authorized use of some tests up to nine months, three months beyond the original expiration dates. Read more »
  • Argentum Releases Visitation Guidance for Vaccinated Senior Living Communities
    Visitation is essential to the health and well-being of senior living residents. Argentum's latest guidance, "Model Visitation Protocols For Vaccinated Senior Living Communities," provides protocols, considerations, and general practices designed specifically for visitation in the variety of spaces and circumstances in senior living communities. This guidance was compiled by clinical… Read more »
  • CDC Releases Guidance for Safe Visitation in Long-Term Care
    The CDC has updated its infection prevention and control recommendations for fully vaccinated people in healthcare settings. These include recommendations for safe visitation in long-term care communities, as well as updated guidance on work restrictions and quarantine for fully vaccinated healthcare providers and residents in healthcare settings. Read more »
  • CDC Releases Interim Public Health Recommendations for Fully Vaccinated People
    Today, the CDC has released the first set of public health recommendations for those who are fully vaccinated. This guidance will be updated and expanded as more information becomes available. Read more »
  • Press Release: Congress Fails Seniors and Caregivers in COVID Relief Package
    (Alexandria, Va.) -- Seniors and their caregivers will be left behind in a $1.9 trillion rescue package that Congress is expected to pass this weekend. Last week, the only proposed funds to support long-term care providers in the American Rescue Plan were eliminated due to “jurisdictional issues,” prior to the… Read more »
  • FDA Issues EUA for Johnson & Johnson COVID-19 Vaccine
    Today, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for the single-dose Janssen COVID-19 vaccine from Johnson & Johnson. This authorization suggests that the benefits outweigh its risks for use in individuals 18 of age or older and permits the vaccine to be distributed in… Read more »
Want to receive instant email notifications on new announcements?

Additional Resources


Senior Living Needs Support for Relief & Resources: We are working to tell Congress what resources senior living needs due to COVID-19.
LEARN MORE

About the CDC’s Resources

The Centers for Disease Control and Prevention (CDC) has a dedicated site for COVID-19 and has posted guidance. Here are some direct links you may find useful:

As new information emerges, the CDC continually updates several special topic pages that may be useful:  

Read an updated a situation summary from the Centers for Disease Control and Prevention.

About the FDA’s Resources 

The U.S. Food and Drug Administration’s FAQs continually provides updates on COVID-19 testing, treatments, and fraud warnings. It has uncovered hundreds of fraudulent and unproven products under its Operation Quack Hack campaign. Here are direct links to some important lists:

About Monoclonal Antibody (mAbs) Treatments 

The FDA authorized monoclonal antibody (mAb) treatments for COVID-19 in November 2020 after these treatments were shown to be effective at combatting the disease. Since then, a pilot program was established by the U.S. Department of Health and Human Services (HHS) to increase access to bamlanivimab (Eli Lilly) for COVID-19 in high-risk, eligible individuals residing or working in long-term care facilities, including assisted living. The program utilizes home infusion providers – in partnership with community staff – to identify, assess, coordinate, dispense, and administer monoclonal antibody therapies in these healthcare settings.

We encourage interested senior living communities to have a protocol mapped out ahead of time, as these treatments must be administered ASAP upon confirmation of COVID-19 symptoms. Without a plan in place, treatment will be delayed.

Assisted living communities and skilled nursing facilities experiencing an outbreak of COVID-19 can locate a home infusion provider from the National Home Infusion Association’s HHS Bamlanivimab Pilot Provider List. Infusion providers are available in most states and can be located using this map.

Once a physician’s order has been issued following a positive COVID-19 test, these providers:

  • Secure the mAb treatments
  • Secure consent for the treatment
  • Administer the treatment in the community using the infusion provider’s PPE
  • Monitor the infusion recipient for one hour following treatment, per protocol
  • Address any adverse reactions to the treatment using an emergency kit the infusion provider brings to the community
  • Handle billing and reimbursement following treatment
Learn more about seeking support for monoclonal antibody treatments

Additional Resources:

Argentum COVID-19 Publications

Published May 2021

Pre-Planning Guidance for OSHA Regulatory Compliance

Support for compliance with OSHA workplace safety regulations
Published March 2021

Model Visitation Protocols for Vaccinated Senior Living Communities

Protocols, considerations, and general practices

Resident Engagement and Socialization During COVID-19

Guidance in preventing resident social isolation
Published November 2020

Argentum Guidance for Infection Prevention and Control

IPC guidance designed for assisted living communities
Updated November 2020

COVID-19 Community Access and Infection Control

FAQs, Sample Screening Checklist
Published October 2020

Essential Caregiver Toolkit

Regulatory model and guidance
Published June 2020

Managing COVID-19 Restrictions

White paper
Published May 2020

The Need for a "Smart" Testing Strategy

White paper

Argentum, its executive staff and consultants, have attempted to provide the best possible information as a service to the association’s membership in a situation that is very quickly evolving and about which so much is unknown. Therefore, Argentum can provide no assurances nor even make any representations about the reliability or accuracy of this information. Each senior living company and each community must make decisions that each regards as in the best interests of the health and safety of the residents. Argentum specifically disclaims responsibility or liability for the information it is providing from any legal, regulatory, medical, or compliance point of view.

Stay Connected

Get updates on the latest news impacting senior living through our Argentum Daily newsletter.

×

Login.

Forgot Password
Create an Account